Tapentadol is partially metabolized by the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with medicine that improve or repress the action/expression of one or more of these enzymes, as well as with substrates of those enzymes (because of competition for that enzyme); some enzyme mediators/substrates need dosing adjustm